In the News

Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

LDN Articles from general news sources

AgelessRx Launches Pilot Post-COVID Clinical Trial Using LDN and NAD (News)
Read More
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone (News)
Read More
Scientists get first look at T cell responses in Ebola virus survivors (News)
Read More
How Chronic Pain Can Lead to Autoimmunity Problems (News)
Read More
Naltrekson ograniczył ból związany z zespołem piekących ust (News)
Read More
McLaughlin leads research on identifying minimally invasive biomarkers for MS (News)
Read More
What is the evidence behind potential Low Dose Naltrexone benefits? (News)
Read More
Chronic fatigue: Drug addiction medicine Naltrexone could treat condition (News)
Read More
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19) (News)
Read More
Low-Dose Naltrexone for Autoimmune and Chronic Pain Conditions, Podcast Interview (News)
Read More
Low-dose naltrexone (LDN) hope for patients with longCOVID syndrome? (News)
Read More
Low-Dose Naltrexone Used as Alternative to Opioids for Chronic Pain Patients (News)
Read More
Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A... (News)
Read More
Low-Dose Naltrexone for Fibromyalgia and ME/CFS (News)
Read More
Calls for the radical treatment (News)
Read More
Research suggests toll-like receptor 4 appears to play role in severe COVID (News)
Read More
6 FAQs About Low Dose Naltrexone (LDN) for Bipolar Disorder (News)
Read More
Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain (News)
Read More
New research gives hope to COVID-19 long haul carriers (News)
Read More
Low Dose Naltrexone (LDN) Increases Endorphin Levels (News)
Read More
Low Dose Naltrexone Emerging as Treatment for Intractable Pain (News)
Read More
Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (News)
Read More
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 (Study)
Read More
Dry eye research reveals impact of disease, potential new treatments (News)
Read More
Medicine specialist talks treatments for lingering COVID-19 symptoms (News)
Read More
How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID (News)
Read More
Addiction Medication Promising for Chronic, Refractory Pain (News)
Read More
Discussing Low-Dose Naltrexone with Sajad Zalzala (News)
Read More
Low-dose naltrexone safe, effective for neuropathic corneal pain (News)
Read More
Synergistic Reduction of Schizophrenia in Animal Models using Low Dose Naltrexone and T Regulatory Cell Stimulation (News)
Read More
Low Dose Naltrexona, na consulta da dor (News)
Read More
Low dose naltrexone: Harnessing the body's own chemistry to treat human ovarian cancer (News)
Read More
World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms (News)
Read More
What to know about LDN for rheumatoid arthritis (News)
Read More
The Use of Naltrexone in Low Doses Beyond the Approved Indication... (News)
Read More
Benefits Of Taking Low Dose Naltrexone (News)
Read More
Can Low-Dose Naltrexone Offer Pain Relief? (News)
Read More
Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients (News)
Read More
FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS) (News)
Read More
Is naltrexone used for pain? (News)
Read More
Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE) (Study)
Read More
Scientist with son who suffers from chronic fatigue syndrome hopes research can help COVID-19 patients (News)
Read More